NON-SMALL CELL LUNG CARCINOMA
Clinical trials for NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to prevent lung cancer recurrence in High-Risk patients
⭐️ VACCINE ⭐️ TerminatedThis study tests a vaccine made from lung cancer cells, combined with an immune-boosting drug (N-803), in people who have had surgery for non-small cell lung cancer (NSCLC) and have no signs of cancer left. The goal is to see if the vaccine can train the immune system to recogniz…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:06 UTC
-
New Vaccine-Immunotherapy combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase study tested a vaccine (p53MVA) plus the drug pembrolizumab in 11 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the combination is safe and can boost the immune system to attack cancer cells. Participant…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
Promising drug duo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests a combination of two drugs, trastuzumab deruxtecan and pembrolizumab, in adults with advanced breast or non-small cell lung cancer that has spread. The goal is to find the safest dose and see how well the combo shrinks tumors. About 115 participants will receive …
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Last-Resort access to targeted lung cancer drug opens for eligible patients
Disease control NO_LONGER_AVAILABLEThis program gives patients with serious non-small cell lung cancer access to the drug capmatinib when no other treatments are available and they cannot join a clinical trial. It is not a study to test the drug, but a way for doctors to request it for individual patients who migh…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Vitamin c boost may help lung cancer treatment work better
Disease control OngoingThis study looks at whether adding high-dose vitamin C (ascorbate) to the usual treatment of radiation and chemotherapy can help people with non-small cell lung cancer. About 43 participants will receive the vitamin C alongside their standard therapy. The goal is to see if this c…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Joseph J. Cullen, MD, FACS • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New drug combo targets hard-to-treat cancers with KRAS mutation
Disease control OngoingThis study tests a new drug called JDQ443, given alone or with other treatments, for people with advanced solid tumors that have a specific change in the KRAS gene (G12C). The goal is to find safe doses and see if the drug can shrink tumors. About 74 adults with lung or colorecta…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New drug combo shows promise against tough lung cancer
Disease control OngoingThis study tests an experimental drug called AZD2936 in people with advanced or metastatic non-small cell lung cancer (NSCLC). The drug is designed to help the immune system fight cancer by blocking two targets (TIGIT and PD-1). The main goals are to check safety and see if the d…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Can acupuncture boost lung cancer treatment?
Symptom relief OngoingThis study looks at whether adding acupuncture to standard immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. About 60 participants will receive either real or sham acupuncture alongside their first four cycles of treatment. The goal is to se…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated May 17, 2026 00:59 UTC
-
New online tool aims to ease emotional burden for women fighting lung cancer
Symptom relief OngoingThis study tests an online program designed to improve social well-being and emotional support for women with non-small cell lung cancer. About 70 women currently receiving treatment will use mindfulness and compassion techniques to help manage distress. The goal is to see if the…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 00:47 UTC
-
Simple blood draws could reveal how cancers evolve during treatment
Knowledge-focused OngoingThis study collects blood samples from 102 people with non-small cell lung cancer, colorectal cancer, or pancreatic cancer to track genetic changes in their tumors over time. Participants receive standard treatments, and researchers analyze DNA from the blood to see how it relate…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: NA • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 17, 2026 01:01 UTC